Unmet Medical Need:  Patients with epilepsy suffer from seizures, cognitive decline, and decreased life expectancy. Approximately one third of patients with epilepsy are drug-resistant and face uncontrolled seizures. While surgical intervention can mitigate symptoms and improve quality of life, surgical treatment of epilepsy is largely underutilized due to its invasiveness, multi-step complexity, and high cost.

Envisioned Healthcare Product: To address the need for a lower-cost, single-step intervention to treat drug resistant epilepsy, the team of Drs. Youngerman and Shepard developed a flexible, wireless, high-resolution neural interface for diagnostic seizure monitoring and therapeutic neuromodulation. Following placement, this device improves real-time neural mapping accuracy and supports therapeutic efficacy without the need for additional surgeries.

Stage of Development:  Pre-clinical testing

Collaborative Research Team:  Brett Youngerman, MD, MS and Kenneth Shepard, PhD

Funding Cycle: 2022-2023